These excellent files are hosted here with zero permission, with every care taken to ensure that they cannot be mistaken as my own work. It is somewhat unusual for something like this to find its home here, as the normal practice is to minimise the opportunities for misinformation in Deranged Physiology by restricting them to one source only. However, to make the Good Guy Notes available to the trainees of That Other College has become morally imperative since the last available link broke down in 2025. Since then, the dispersion of these resources has become sporadic and unreliable, exchanged from trainee to trainee, with larger centres benefiting from local file sharing and with isolated rural or regional trainees deprived of access.
The contributors to them are likely numerous, and the document metadata only lists "Eddie" as the author, making it impossible to correctly attribute the credit, or to ask for permission, or for that matter, forgiveness. One can only surmise, from the massive extent of the project, the enormous effort it must have taken to compile it, and the free circulation of these among ANZCA trainees, that the creators must have felt some level of altruistic magnanimity towards their fellows, would encourage the beneveolent distribution of their works, and quietly enjoy the anonymous fame from their ongoing popularity. My hat is off to you, colleagues.
Complete collection |
|
Those unwilling to scroll this impossible list can instead |
Pharmacology |
General |
Anti-emetic SAQs and MCQs |
|
Pharm05A1 — Antiemetics — drug classes, examples and adverse effects |
|
Pharm05B7 — Pharmacology of droperidol including mechanism, perioperative use and side effects |
|
Pharm97B16 — Dopamine receptors location and function with agonist/antagonist examples |
|
Pharm98B10 — Sites of action for antiemetic agents against PONV |
Cardiovascular drugs SAQs and MCQs |
|
Pharm01A15 — Beta-blockers — esmolol and propranolol pharmacology compared |
|
Pharm02A13 — Side-effects of amiodarone during anaesthesia |
|
Pharm02B7 — Pharmacological advantages and disadvantages of intra-operative beta-blockade |
|
Pharm03B6 — Clinical uses and limitations of alpha-2 agonists including clonidine |
|
Pharm04A6 — Circulatory effects of glyceryl trinitrate |
|
Pharm05A7 — Neurotransmitter systems — noradrenergic transmission and MAO inhibitors |
|
Pharm05A8 — Pathology of anaphylaxis and epinephrine treatment |
|
Pharm05B8 — Adverse effects of beta adrenoreceptor antagonists |
|
Pharm06B1 — Use of sympathomimetics for hypotension post subarachnoid block |
|
Pharm06B7 — Drug and non-drug treatment of VF with mechanisms |
|
Pharm07A8 — Classes of drugs for chronic left ventricular failure and their mechanisms |
|
Pharm08A2 — Diuretic classes and their mechanisms |
|
Pharm08A8 — Metoprolol, GTN and diltiazem for myocardial ischaemia |
|
Pharm08B3 — Anaesthetic uses of clonidine and effects on cardiovascular and CNS |
|
Pharm09B7 — Pharmacological management of ventricular fibrillation |
|
Pharm10B3 — Mechanism, pharmacokinetics and side effects of intravenous amiodarone |
|
Pharm11A5 — Antihypertensive drugs — classes for hypertensive crisis and mechanisms |
|
Pharm11B3 — Mechanism, therapeutic uses and side effects of beta-adrenoreceptor antagonists |
|
Pharm96A15 — Pharmacology and anaesthetic uses of adenosine |
|
Pharm99A16 — Clonidine and other alpha-2 agonists — effects in anaesthesia |
|
Pharm99B12 — Mechanism and treatment of sodium nitroprusside toxicity |
Chemotherapeutics and poisoning SAQs and MCQs |
|
Pharm98A11 — Pharmacological implications of gentamicin during anaesthesia |
|
Respiratory pharmacology, chemotherapeutics and poisoning MCQ |
Drug variability and pharmaceutics SAQs and MCQs |
|
Pharm00B15 — Anaphylaxis — latex allergy |
|
Pharm03A4 — Problems caused by additives in intravenous medicines |
|
Pharm06A2 — Drug isomerism and its anaesthetic significance |
|
Pharm06B3 — Variability in response to intravenous anaesthetic induction agents |
|
Pharm07A2 — Epidural pharmacokinetics — bupivacaine distribution in pregnancy |
|
Pharm07A3 — Variability in therapeutic response to opioid analgesics |
|
Pharm08B5 — Neonatal pharmacokinetics — morphine, bupivacaine and suxamethonium |
|
Pharm09B4 — Effect of obesity on pharmacokinetics and clinical implications |
|
Pharm11A3 — Liver failure and drug response — kinetic and dynamic effects |
|
Pharm11B7 — Acute management of malignant hyperthermia and dantrolene pharmacology |
Drugs and coagulation SAQs and MCQs |
|
Pharm02A15 — Coumarin anticoagulation: mechanism, onset and offset |
|
Pharm04A8 — Side effects and complications of heparin therapy |
|
Pharm07B2 — Perioperative interruption of warfarin and bridging with LMWH |
|
Pharm08B7 — Agents reducing platelet function, mechanisms, side effects, elimination and duration |
|
Pharm11B5 — Mechanism of action and side effects of protamine |
|
Pharm95B4 — Chemistry of heparin, mechanism of action and toxic effects |
|
Pharm99A15 — Anticoagulant and antithrombotic drug classes and mechanisms |
Endocrine pharmacology SAQs and MCQs |
|
Pharm02B8 — Pharmacological effects of vasopressin |
|
Pharm05B6 — Therapeutic and unwanted effects of dexamethasone |
|
Pharm10A6 — Oral hypoglycaemic drugs — classes, mechanisms and examples |
GI pharmacology SAQs and MCQs |
|
Pharm05A6 — Drugs that reduce gastric acidity: mechanisms and trade-offs |
Histamine and serotonin SAQs and MCQs |
|
Pharm01B14 — Direct effects of endogenous histamine |
|
Pharm04B3 — Histamine effects and H1 blocker pharmacology |
|
Pharm08A5 — Serotonergic drug classes, mechanisms and indications |
|
Pharm09A7 — Serotonin receptor subtypes and pharmacological agents |
Inhalational agent SAQs and MCQs |
Intravenous agent SAQs and MCQs |
|
Pharm00B14 — Cardiovascular effects of propofol and ketamine compared |
|
Pharm01A13 — Non-ideal features of propofol as IV induction agent |
|
Pharm02A11 — Non-CNS effects of thiopentone and ketamine |
|
Pharm02A16 — Pharmacology of flumazenil |
|
Pharm03A2 — Effects of thiopentone on EEG, cerebral blood flow and intracranial pressure |
|
Pharm04B7 — Factors influencing propofol elimination half-life |
|
Pharm06A4 — Pharmacodynamic properties of propofol and clinical usage |
|
Pharm07A4 — Ketamine and propofol for total intravenous anaesthesia |
|
Pharm09B2 — Potential side effects of propofol and formulations |
|
Pharm10A4 — Effect-site equilibration — delay from IV injection to loss of consciousness |
|
Pharm10B6 — Computer-controlled propofol infusion targeting a constant effect-site level |
|
Pharm11A4 — Ideal properties of sedation agents with examples |
IV fluids SAQs and MCQs |
|
Pharm08B6 — Ideal properties of colloid IV fluids with examples |
|
Pharm10B2 — Composition and comparison of 4% albumin and Normal Saline |
Local anaesthetic SAQs and MCQs |
|
Pharm01B11 — Local anaesthetics — topical formulations |
|
Pharm03A3 — Mechanism of action of lignocaine on nerve action potential |
|
Pharm04A3 — Local anaesthetics — skin penetration and EMLA formulation |
|
Pharm04B2 — Pharmacology of ropivacaine |
|
Pharm06A5 — Local anaesthetic block — factors affecting onset and duration |
|
Pharm08A6 — Safe topical doses and toxic effects of cocaine and lignocaine |
|
Pharm10A1 — Chemical structure's impact on local anaesthetic efficacy and safety |
|
Pharm11A1 — Risk factors for amide local anaesthetic systemic toxicity |
|
Pharm97A13 — Local anaesthetic pharmacology — bupivacaine physicochemistry and effects |
Neuropharmacology SAQs and MCQs |
|
Pharm10A8 — Antidepressant classes and perioperative drug interactions |
NMBD, Anticholinergic and AChEi SAQs and MCQs |
|
Neuromuscular blocking agents, Anticholinergic drugs and Anticholinesterases MCQ |
|
Neuromuscular blocking drugs, Anticholinesterases, and Anticholinergic drugs SAQs |
|
Pharm00B16 — Atracurium and cisatracurium pharmacology compared |
|
Pharm02B5 — Causes and consequences of prolonged suxamethonium paralysis |
|
Pharm03A8 — Vecuronium block at the diaphragm, larynx and adductor pollicis |
|
Pharm04A2 — Determinants of neuromuscular-blocker onset |
|
Pharm05A4 — Drug inhibition of cholinergic transmission at the neuromuscular junction |
|
Pharm06A6 — Prolonged non-depolarising neuromuscular blockade after prolonged surgery |
|
Pharm06B4 — Rocuronium for rapid-sequence induction |
|
Pharm07A1 — Postoperative adverse effects of neostigmine |
|
Pharm07B6 — Suxamethonium blockade, recovery and phase II block |
|
Pharm08A7 — Train-of-four and double-burst neuromuscular monitoring |
|
Pharm09A3 — Determinants of recovery from non-depolarising neuromuscular block |
|
Pharm09B5 — Reduced response to non-depolarising neuromuscular blockers |
|
Pharm10A2 — Methods and limitations of neuromuscular-block depth monitoring |
|
Pharm10B5 — Effects and uses of anticholinesterase drugs |
|
Pharm11A8 — Neuromuscular junction — drug enhancement of non-depolarising blockade |
|
Pharm97A12 — Acetylcholinesterase inhibitors — edrophonium, neostigmine and organophosphates |
|
Pharm98A15 — Suxamethonium and atracurium metabolism compared |
|
Pharm98B13 — Log dose-response curve for vecuronium: characteristics and clinical factors |
|
Pharm99A11 — Atropine, hyoscine and glycopyrrolate compared |
|
Pharm99A12 — Phenomena of fade and post tetanic facilitation with neuromuscular blocking agents |
Obstetric pharmacology SAQs and MCQs |
|
Pharm00A12 — Pharmacology of oxytocin |
|
Pharm02B1 — Pharmacokinetics in pregnancy — major influences |
|
Pharm09B6 — Pharmacodynamics of drugs affecting uterine tone |
|
Pharm95B6 — Pharmacokinetics in pregnancy — major influences |
Opioid agonist and antagonist SAQs and MCQs |
|
Pharm00A15 — Effects of opioids on the respiratory system |
|
Pharm02B6 — Tolerance and dependence in opioid analgesics |
|
Pharm03A6 — Pharmacokinetics — alfentanil and fentanyl compared |
|
Pharm05A2 — Acute adverse effects of opioid receptor agonists |
|
Pharm07B3 — Conversion from intravenous morphine to oral opioid analgesia |
|
Pharm09A5 — Intrathecal drug pharmacokinetics — opioid effects |
|
Pharm10B1 — Pharmacokinetics — oral vs intravenous morphine and oxycodone |
|
Pharm11A6 — Pharmacology of remifentanil |
|
Pharm11B6 — Opioid pharmacology — morphine and fentanyl patient-controlled analgesia |
|
Pharm96A11 — Pharmacokinetics — pethidine |
|
Pharm96B9 — Determinants of fentanyl duration after intravenous bolus |
Pain and NSAID SAQs and MCQs |
|
Pharm08B4 — Ketamine pharmacology and postoperative analgesia |
|
Pharm10A5 — NSAID clinical effects and COX-2 selective advantages/disadvantages |
|
Pharm11A2 — Non-opioid drugs for neuropathic pain |
|
Pharm11B4 — Paracetamol toxicity pathogenesis and management |
Pharmacodynamics SAQs and MCQs |
|
Pharm00B11 — Structure and function of G proteins |
|
Pharm03B3 — GABA neurotransmission and its pharmacological modification |
|
Pharm04B1 — Mechanisms of drug action |
|
Pharm05B2 — Opioid pharmacology concepts illustrated with graphs |
|
Pharm10A7 — Nicotinic acetylcholine receptor pharmacology |
|
Pharmacokinetics, pharmacodynamics, drug variability and pharmaceutics MCQ |
Pharmacokinetics SAQs and MCQs |
|
Pharm00A14 — Plasma esterases roles in anaesthetic drugs |
|
Pharm02A10 — Recovery factors after drug infusion |
|
Pharm02B2 — Gastrointestinal drug absorption — factors affecting oral uptake |
|
Pharm05B4 — Context sensitive half time and comparison |
|
Pharm11B2 — Two compartment model and propofol |
|
Pharm96A13 — Transdermal drug factors and examples |
Respiratory pharmacology SAQs and MCQs |
Statistics SAQs and MCQs |
|
Pharm08B8 — Design of a randomised controlled trial |
|
Pharm09B8 — Statistical analysis of placebo and treatment blood-pressure data |
Physiology |
General |
Acid Base Physiology SAQs and MCQs |
|
Physiol06B15 — Metabolic acidosis in hypovolaemic shock |
|
Physiol07A11 — Body handling of metabolic acidosis |
|
Physiol08A11 — Physiological consequences of DKA |
|
Physiol10B15 — Role of haemoglobin as a buffer |
|
Physiol95A6 — Effects of intravenous sodium bicarbonate in asystolic cardiac arrest |
Acid Base Physiology SAQs and MCQs / Acid Base Physiology SAQs and MCQs |
|
Physiol06B15 — Metabolic acidosis in hypovolaemic shock |
|
Physiol07A11 — Body handling of metabolic acidosis |
|
Physiol08A11 — Physiological consequences of DKA |
|
Physiol10B15 — Role of haemoglobin as a buffer |
|
Physiol95A6 — Effects of intravenous sodium bicarbonate in asystolic cardiac arrest |
Cellular Physiology SAQs and MCQs |
|
Physiol01B5 — Structure and function of voltage-sensitive ion channels |
|
Physiol04B15 — Mechanism of action of G-proteins in the cell |
|
Physiol06A12 — Cellular and molecular mechanisms of neurotransmitter action |
|
Physiol10A16 — Processes for substance crossing cell membranes |
|
Physiol11B9 — Physiological roles of prostaglandins |
|
Physiol91 ER — Structure and functions of the endoplasmic reticulum |
|
Physiol93B3 — Role of intercellular tight junctions |
|
Physiol98B7 — Structure and metabolic processes of mitochondria |
Cellular Physiology SAQs and MCQs / Cellular Physiology SAQs and MCQs |
|
Physiol01B5 — Structure and function of voltage-sensitive ion channels |
|
Physiol04B15 — Mechanism of action of G-proteins in the cell |
|
Physiol06A12 — Cellular and molecular mechanisms of neurotransmitter action |
|
Physiol10A16 — Processes for substance crossing cell membranes |
|
Physiol11B9 — Physiological roles of prostaglandins |
|
Physiol91 ER — Structure and functions of the endoplasmic reticulum |
|
Physiol93B3 — Role of intercellular tight junctions |
|
Physiol98B7 — Structure and metabolic processes of mitochondria |
Clinical Measurements SAQs and MCQs |
Clinical Measurements SAQs and MCQs / Clinical Measurements SAQs and MCQs |
|
Physiol02A7 — Measurement principles — pneumotachograph operation and accuracy |
|
Physiol04A14 — Differences between laminar and turbulent flow |
|
Physiol04B11 — Estimating blood oxygen partial pressure by oximetry |
|
Physiol06A15 — Blood pH measurement with an electrode |
|
Physiol08B9 — Humidity and its measurement |
|
Physiol10B11 — Physical principles of ultrasound imaging |
|
Physiol11A16 — Effects of viscosity and density on gas and liquid flow |
|
Physiol95B7 — Heat, temperature and thermistor principles |
|
Physiol99A5 — Heat, temperature and mercury thermometer principles |
|
Physiol99B1 — How temperature fall affects blood gas solubility and acid base values |
|
Physiol99B7 — Oxygen partial-pressure measurement with the Clark electrode |
CVS SAQs and MCQs |
CVS SAQs and MCQs / CVS SAQs and MCQs |
|
Cardiovascular Physiology - Applied aspects of CVS physiology |
|
Cardiovascular Physiology - Determinants and control of cardiac output |
|
Cardiovascular Physiology - Electrical properties of the heart |
|
Cardiovascular Physiology - Structure and function of the heart |
|
Physiol01B1 — Effects of IPPV on left ventricular output |
|
Physiol02A2 — Draw cardiac action potential diagram; explain threshold, excitability and irritability |
|
Physiol02B11 — Coronary blood flow — determinants of vascular resistance |
|
Physiol02B9 — Ventricular pressure–volume loops and their interpretation |
|
Physiol03A10 — Determinants of hepatic blood flow |
|
Physiol03A12 — Postural maintenance of cerebral blood flow |
|
Physiol03A13 — Oscillometric blood pressure measurement and sources of error |
|
Physiol03B10 — Baroreceptor control of systemic arterial pressure |
|
Physiol03B9 — Effects of tachycardia on myocardial oxygen supply and demand |
|
Physiol04A10 — Endothelial vasoactive substances and peripheral blood-flow regulation |
|
Physiol04B10 — Physiological determinants of left atrial pressure |
|
Physiol04B16 — Physiological mechanisms of interstitial oedema |
|
Physiol05A14 — Baroreflex — compensatory responses to standing |
|
Physiol05A16 — Doppler ultrasound measurement of cardiac output |
|
Physiol06A9 — Systemic cardiovascular response to exercise |
|
Physiol07A13 — Determinants of venous return and effects of anaesthesia |
|
Physiol07A15 — Resonance and damping effects on arterial pressure traces |
|
Physiol07B16 — Lead II ECG cycle, normal values and the PR interval |
|
Physiol07B9 — Cardiovascular response to central neural blockade |
|
Physiol08A14 — Referred pain pathways in myocardial ischaemia |
|
Physiol08A9 — High organ blood flow in skin, kidneys and carotid bodies |
|
Physiol08B14 — Severe aortic stenosis and myocardial oxygen balance |
|
Physiol09A13 — Frank-Starling mechanism and excitation-contraction coupling |
|
Physiol09B9 — Causes of early postoperative hypotension |
|
Physiol10A13 — Autonomic control — cardiac innervation and function |
|
Physiol10B10 — Determinants of coronary blood flow |
|
Physiol11A10 — Afterload — factors opposing left ventricular ejection |
|
Physiol11B11 — Pacemaker-cell automaticity — ionic basis |
|
Physiol97B1 — Effects of reduced plasma oncotic pressure in skeletal muscle capillaries |
|
Physiol99A8 — Plasma oncotic pressure in capillary fluid exchange |
|
Physiol99B8 — Invasive blood pressure — aortic-root and radial-artery waveforms |
CVS SAQs and MCQs / Goods |
|
Cardiovascular Physiology - Applied aspects of CVS physiology |
|
Cardiovascular Physiology - Determinants and control of cardiac output |
|
Cardiovascular Physiology - Electrical properties of the heart |
|
Cardiovascular Physiology - Structure and function of the heart |
Fluids and Electrolytes SAQs and MCQs |
|
Physiol-95 acid base — Metabolic alkalosis from small-bowel obstruction and gastric losses |
|
Physiol05A11 — Water deficit — detection and physiological response |
|
Physiol05B12 — Physiological roles of plasma proteins |
|
Physiol09A11 — Determinants and regulation of extracellular fluid volume |
|
Physiol95B5 — Effects and complications of intravenous mannitol |
|
Physiol96A7 — Osmosis — solvent and solute movement across a semipermeable membrane |
Fluids and Electrolytes SAQs and MCQs / Fluids and Electrolytes SAQs and MCQs |
|
Physiol-95 acid base — Metabolic alkalosis from small-bowel obstruction and gastric losses |
|
Physiol05A11 — Water deficit — detection and physiological response |
|
Physiol05B12 — Physiological roles of plasma proteins |
|
Physiol09A11 — Determinants and regulation of extracellular fluid volume |
|
Physiol95B5 — Effects and complications of intravenous mannitol |
|
Physiol96A7 — Osmosis — solvent and solute movement across a semipermeable membrane |
Gastrointestinal and Liver SAQs and MCQs |
Gastrointestinal and Liver SAQs and MCQs / Goods |
Haematology SAQs and MCQs |
|
Physiol01B7 — Intrinsic and extrinsic coagulation pathways compared |
|
Physiol05B11 — Blood compatibility testing before transfusion |
|
Physiol06A11 — Role of platelets in haemostasis |
|
Physiol07A10 — Coagulation — mechanisms preventing it in intact vessels |
|
Physiol07B13 — Why O-negative blood is safe for emergency transfusion |
|
Physiol09B12 — Production and functions of red blood cells |
|
Physiol09B15 — Structure and functions of the complement system |
|
Physiol10A10 — White blood cell defence mechanisms |
|
Physiol10A12 — Stored blood — physiological changes |
|
Physiol11B12 — Myoglobin and adult haemoglobin compared |
Haematology SAQs and MCQs / Goods |
Maternal, Foetal, Neonatal SAQs |
|
Physiol02B16 — Bohr and Haldane effects in placental gas exchange |
|
Physiol07A14 — Gas transfer limits — facilitation of placental oxygen transfer |
|
Physiol09B10 — Neonatal respiratory system — comparison with adults |
Maternal, Foetal, Neonatal SAQs / Maternal, Foetal, Neonatal SAQs |
|
Physiol02B16 — Bohr and Haldane effects in placental gas exchange |
|
Physiol07A14 — Gas transfer limits — facilitation of placental oxygen transfer |
|
Physiol09B10 — Neonatal respiratory system — comparison with adults |
Muscle Physiology SAQs and MCQs |
|
Physiol01A2 — Muscle tension and shortening velocity |
|
Physiol05B14 — Smooth muscle excitation and contraction |
|
Physiol06B13 — Structure–function relationships of skeletal muscle fibres |
|
Physiol11A12 — Twitch and tetanic muscle contractions compared |
Muscle Physiology SAQs and MCQs / Muscle Physiology SAQs and MCQs |
|
Physiol01A2 — Muscle tension and shortening velocity |
|
Physiol05B14 — Smooth muscle excitation and contraction |
|
Physiol06B13 — Structure–function relationships of skeletal muscle fibres |
|
Physiol11A12 — Twitch and tetanic muscle contractions compared |
Nervous System SAQs and MCQs |
|
Physiol00B6 — Physiological control of intraocular pressure |
|
Physiol03B15 — NMDA receptor physiology in the central nervous system |
|
Physiol04A15 — Intracranial pressure factors and regulation |
|
Physiol08B11 — Physiological changes during sleep |
|
Physiol09A2 — Generation and maintenance of the resting membrane potential |
|
Physiol09B14 — Cerebral blood flow — effects of carbon dioxide on the CNS |
|
Physiol10B14 — Intracranial pressure — effects of head-down tilt |
|
Physiol11B13 — Production, fate and physiological roles of cerebrospinal fluid |
|
Physiol94_action potential — Nerve action potential: graph and ionic basis |
|
Physiol96B1 — Mechanisms of failed synaptic transmission |
|
Physiol97A5 — Saltatory conduction and its advantages |
Nervous System SAQs and MCQs / Nervous System SAQs and MCQs |
|
Physiol00B6 — Physiological control of intraocular pressure |
|
Physiol03B15 — NMDA receptor physiology in the central nervous system |
|
Physiol04A15 — Intracranial pressure factors and regulation |
|
Physiol08B11 — Physiological changes during sleep |
|
Physiol09A2 — Generation and maintenance of the resting membrane potential |
|
Physiol09B14 — Cerebral blood flow — effects of carbon dioxide on the CNS |
|
Physiol10B14 — Intracranial pressure — effects of head-down tilt |
|
Physiol11B13 — Production, fate and physiological roles of cerebrospinal fluid |
|
Physiol94_action potential — Nerve action potential: graph and ionic basis |
|
Physiol96B1 — Mechanisms of failed synaptic transmission |
|
Physiol97A5 — Saltatory conduction and its advantages |
Nutrition, Metabolism, Endocrine SAQs and MCQs |
Nutrition, Metabolism, Endocrine SAQs and MCQs / Nutrition, Metabolism, Endocrine SAQs and MCQs |
Renal Physiology SAQs and MCQs |
Renal Physiology SAQs and MCQs / Renal Physiology SAQs and MCQs |
Respiratory Physiology SAQs and MCQs |
Respiratory Physiology SAQs and MCQs / Notes and Qs |
|
Respiratory Physiology - Diffusive transfer of respiratory gases |
|
Respiratory Physiology - Pulmonary gas volumes and ventilation |
Thermoregulation SAQs and MCQs |
|
Physiol01A5 — Role of the skin in temperature regulation |
|
Physiol08A10 — Thermoneutral zone and temperature regulation |
|
Physiol11A14 — Effects of general anaesthesia on temperature regulation |
|
Physiol93A3 — Physiological consequences of hypothermia |
Thermoregulation SAQs and MCQs / Thermoregulation SAQs and MCQs |
|
Physiol01A5 — Role of the skin in temperature regulation |
|
Physiol08A10 — Thermoneutral zone and temperature regulation |
|
Physiol11A14 — Effects of general anaesthesia on temperature regulation |
|
Physiol93A3 — Physiological consequences of hypothermia |
